tbuckley/cabot-search huggingface dataset:
Neural Science
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Department of Public Health.
Authors: John A. Benson
Journal: JAMA (1898)

Chicago, Ill., Jan. 11, 1898. <h3>To the Editor:</h3> —I have been reading with interest the various notices in theJournalrelative to the establishment of a Department of Public Health at the National Capitol and the furtherance of such legislative enactments as will tend toward the preservation of the public health. Early in 1893 I advocated such measures and devoted attention to the question in a treatise on Asiatic cholera written and published by me in that year. There is one pronounced element of danger in connection with the favored change and to this I would respectfully call the attention of my professional colleagues. This is the fact that peradventure some "practical politician" would be made the Secretary in charge of the new portfolio instead of a medical hygienist. The ridiculous and unfortunate state of affairs that would be induced under these circumstances need hardly be dilated upon. The proper
LETTER FROM PARIS.
Authors: None A. M. G.
Journal: JAMA (1890)

(FROM OUR REGULAR CORRESPONDENT.) <i>The Chirurgical Treatment of Tuberculous Peritonitis</i>. At a meeting of the Chirurgical Clinic at the Hôpital de la Salpêtrière, M. le docteur Terrillon took for his lecture the following interesting study, viz.: "The Chirurgical Treatment of Tuberculous Peritonitis." A report of this lecture is just published of which I here give the contents. We are about to study to-day an affection which has for a long time almost exclusively belonged to medicine, but which falls more and more under the dominion of surgery. I wish to speak of tuberculous peritonitis, of which we have, at this moment, an interesting example in our hospital. You have been able to see, just now, in my ward, a young girl of sixteen years, pale, meagre, who presents a particular deformation of the abdominal region. The stomach is globulous, pointing forwards, as that of a woman affected with a cyst
Rheumatoid nodules and rheumatoid granulomas in systemic lupus erythematosus
Authors: E. L. Dubois
Journal: JAMA (1972)

Rheumatoid granulomas may occur in classic systemic lupus erythematosus (SLE) as either an early or late manifestation of the disease. Nine patients had biopsy-proven granulomas, six in subcutaneous nodules of the elbow, two in synovial tissue, and one in the wall of a giant dissecting synovial cyst. Three patients had chronic deforming nonerosive polyarthritis characterized by extensive destruction of capsular tissues, ulnar deviation, and subluxation deformity of the postrheumatic fever or Jaccoud type. Rheumatoid granulomas were found in the synovium of the metacarpophalangeal joint in two of them and in a giant dissecting synovial cyst of the elbow in one. The occurrence of rheumatoid granulomas in both SLE and rheumatoid arthritis emphasizes the close association of the two disorders and that rheumatoid granulomas in adults are not unique to rheumatoid arthritis.
Diseases of the Veins and Lymphatics of the Lower Extremity: A Manual of Veins and Lymphatics of the Lower Extremity for Students and Practitioners
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Rates of depression among men in Scotland have risen since 1980
Journal: BMJ (1998)

Some small for gestational age fetuses have higher risk of late fetal death than othersIn small for gestational age fetuses, without congenital malformations, constitutionally small fetuses-for example twins or the fetuses of short mothers-have been assumed to at lower risk of late fetal death than fetuses affected by conditions such as pre-eclampsia or cigarette consumption.Cnattingius et al (p 1483) tested that assumption in over 1 million births in the Swedish birth register.Overall, late fetal mortality was increased in women who were over 35, nulliparous, smoked, or were <155 cm tall and greatly increased in those with pre-eclampsia, essential hypertension, and twin pregnancies.But in very small for gestational age fetuses death rates were lower in women aged under 35, <155 cm tall, with twins, or with severe eclampsia or hypertension.
Selected New Books
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Probiotics in the Prevention of IgE-Associated Eczema: a Double Blind Randomised Placebo-Controlled Trial
Authors: T. Abrahamsson, T. Jakobsson, M. Fagerås Böttcher, M. Fredrikson, M.C. Jenmalm, B. Björkstén, G. Oldaeus
Journal: Journal of Allergy and Clinical Immunology (2007)
Clinical Lectures on Lithotomy
Authors: S. Smith
Journal: BMJ (1859)

LECTURE III.GENTLEMEN,-The last case that I related before we parted was that of an old gentleman who had a stone of considerable size in the bladder, and who, after taking mephitic water for several years, and expelling much fine sand, at length expelled also the nucleus of a calculus; after which he was cured of his symptoms of stone, and lived many years.In that case, the strong hereditary tendency to the disease is thus proved.His father died with a large stone in the bladder; and his only brother also died witlh several large urinary calculi in the blad- der, which were removed after death.I think, from the circum- stance of his having, expelled four lithic acid calculi before such urgent symptoms of stone took place as induced me to sound him; from my finding a stone in his bladder; from the fact that the symptoms were so manifold that he requested an operation; from the fact that Mr. Costello saw him, injected the bladder, and in my presence felt and heard a stone;-from this combination of circumstances, I think, you will rather agree with mny opinion than with that of the gentlemen who de- nied that there had been a stone in the bladder, because one was not found after death.Case No. 21-John George, operated on September 16th, 1830, is a case worthy of remark, as proving, the early period of life at wlhich a stone can be formed in the bladder.This boy was 2i years of age, and made an excellent recovery.On the 4th of Febr-uary, 1829, I remiioved from his urethra this small calculus, when, of course, he was only sixteen months old, and when he had probably partaken of no other food but his motier's milk.
Hematology
Authors: Gerald J. Roth
Journal: JAMA (2005)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment
Authors: Walter Ageno, David Garcia, Maria I. Aguilar, James Douketis, Guido Finazzi, Davide Imberti, Alfonso Iorio, Nigel S. Key, Wendy Lim, Marco Marietta, Domenico Prisco, Ravi Sarode, Sophie Testa, Alberto Tosetto, Mark Crowther
Journal: American Journal of Hematology (2009)
BCL‐2 oncoprotein (p26) in splenic lymphoma with villous lymphocytes: A comparative study with other chronic B‐cell disorders
Authors: Margarida Lima, Maria dos Anjos Teixeira, Maria Luís Queirós, Ana Helena Ribeiro dos Santos, Benvindo Justiça
Journal: American Journal of Hematology (1997)

We compared the expression of the BCL-2 oncoprotein (p26) on B cells from 24 patients with splenic lymphoma with circulating villous lymphocytes (SLVL) with that observed on normal, mature B lymphocytes and on neoplastic B cells from 91 patients with other chronic B-cell malignancies. SLVL B cells showed levels of p26 intermediate between those found on normal B lymphocytes and on neoplastic B cells from patients with other chronic B-cell lymphoproliferative disorders. Am. J. Hematol. 56:122–125, 1997. © 1997 Wiley-Liss, Inc.
Patient factors largely explain variation in GP admission rates
Journal: BMJ (1999)

Treatment for athlete's foot should begin with over the counter drugs On p 79 Hart et al report the first systematic review of topical antifungal drugs for athlete's foot.Allylamines, available only on prescription, cure slightly more fungal infections of the skin of the feet than azoles and undecenoic acid, both of which are available over the counter.The comparatively high cost of allylamines, however, means that the few extra cures are expensive.So it is best to begin treatment with an azole or undecenoic acid, and to reserve allylamines for those infections that do not respond.
The Environment
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
NEW REMEDIES.
Authors: J. CHRIS. LANGE
Journal: JAMA (1885)

Mr. President and Gentlemen:\p=m-\In order that the scope of this paper may be understood at the outset, it is necessary to state to what preparations and productions the name, New Remedies, is therein appl i ed; and, also, that the paper is limited to a desultory consideration of the popularity, in the professi on, of new remedies, of the foundation of this popularity, and of some conclusions that may be adduced from it.The class of therapeutical agents to be herein considered in the limited aspect which has been in dicated, embraces, under the generic name of New Remedies, all preparations and productions not officinal in the United States nor foreign phar macop\ l =oe\ i as, with the single exception of that very limited number of such agents which have been proven, beyond reasonable doubt, to possess the qualities attributed to them; this proof being founded upon evidence furnished by an extended clinical experi¬ ence, at various hands, irrespective of and uninflu¬ enced by the results of theoretical speculations, of chemical or microscopical researches, and of experi¬ ments on animals.
The vulnerable period for low and high energy T-wave shocks: Role of dispersion of repolarisation and effect of d-sotalol
Authors: P Kirchhof
Journal: Cardiovascular Research (1996)

Introduction: The induction of ventricular fibrillation (VF) by T-wave shocks has been related to dispersion of repolarisation, but only indirect evidence of this hypothesis exists. The effects of drugs prolonging repolarisation like d-sotalol on the vulnerability to T-wave shocks remain unknown. Methods: In 9 isolated rabbit hearts, 7 monophasic action potentials (MAPs) and an ECG were recorded simultaneously. Vulnerable periods were determined using two different shock strengths, one close to the fibrillation threshold and the other close to the upper limit of vulnerability, at baseline and after action potential prolongation by d-sotalol. Results: The vulnerable period had a duration of 30 ± 14 ms for the lower and 34 ± 12 ms for the higher shock strength (P = NS). Coupling intervals of the vulnerable periods were 13 ± 10 ms shorter for higher shock strengths as compared to lower shock strengths (P < 0.005). The vulnerable period for low shock strengths coincided with dispersion of MAPs at 90% repolarisation (r = 0.8−;0.92, P < 0.005), and the vulnerable period for high shock strengths coincided with dispersion at 70% repolarisation (r = 0.82−0.93, P < 0.005). ECG parameters predicted the vulnerable periods less precisely than MAP repolarisation (r ≤ 0.72). d-Sotalol prolonged MAP durations by an average of 33 ms at 70% and 39 ms at 90% repolarisation but did not alter the described relations, nor did it reduce dispersion of repolarisation or duration of the vulnerable periods. Conclusions: Dispersion of repolarisation determines vulnerable periods and might be part of the arrhythmogenic substrate promoting induction of VF by T-wave shocks. The coupling intervals of the vulnerable periods depend on the applied shock strength as well as repolarisation, with shock strengths close to the fibrillation threshold inducing VF during dispersion at 90% repolarisation and shock strengths close to the upper limit of vulnerability inducing VF during dispersion at 70% repolarisation. d-Sotalol reduces neither vulnerability to T-wave shocks nor dispersion of repolarisation in this isolated heart model.
Scanning for tumors of brain and bone. Comparison of sodium pertechnetate Tc 99m and ionic strontium 87m
Authors: D. E. Tow
Journal: JAMA (1967)

Visualization by radioisotope scanning of areas of abnormal accumulation of radioactivity can be used to diagnose lesions such as brain tumors. The possibility that more precise diagnosis might be possible because of tissue specificity for different radiopharmaceuticals led us to compare the relative uptakes of radioactive pertechnetate and ionic strontium in brain and bone lesions. The results in experimental animals and man indicated that sodium pertechnetate Tc 99m was superior to strontium 87m for delineating brain tumors. Ionic strontium was more specific than pertechnetate in delineating bone tumors although pertechnetate also accumulated in such lesions. Because of the relative specificity of pertechnetate for delineating brain tumors and of ionic strontium for demonstrating bone tumors, the use of both nuclides was of value in the differential diagnosis of tumors in bone and brain. Their use was particularly helpful in distinguishing lesions of the skull from brain tumors.
Omitted Author Contributions
Journal: JAMA (2019)

Charles L. Sprung, MD; Bara Ricou, MD; Christiane S. Hartog, MD; Paulo Maia, MD; Spyros D. Mentzelopoulos, MD, PhD; Manfred Weiss, MD; Phillip D. Levin, MB, BChir; Laura Galarza, MD; Veronica de la Guardia, MD; Joerg C. Schefold, MD; Mario Baras, PhD; Gavin M. Joynt, MBBCh; Hans-Henrik Bülow, MD; Georgios Nakos, MD, PhD; Vladimir Cerny, MD, PhD; Stephan Marsch, MD, DPhil; Armand R. Girbes, MD, PhD; Catherine Ingels, MD, PhD; Orsolya Miskolci, MD; Didier Ledoux, MD; Sudakshina Mullick, MD; Maria G. Bocci, MD; Jakob Gjedsted, MD, PhD; Belén Estébanez, MD; Joseph L. Nates, MD, MBA, CMQ; Olivier Lesieur, MD, PhD; Roshni Sreedharan, MD; Alberto M. Giannini, MD; Lucía Cachafeiro Fuciños, MD, PhD; Christopher M. Danbury, MB, BS, MPhil; Andrej Michalsen, MD, MPH; Ivo W. Soliman, MD; Angel Estella, MD; Alexander Avidan, MD
Device Produces Clear Image Scan in Short Time
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Drug Combination
Authors: Kenneth B. Brilhart
Journal: JAMA (1971)

<h3>To the Editor.—</h3> Your attention is called to an error in McMahon's communication on "Drug Combinations" (<b>216</b>:1008,1971). "Afrin"for relief of congestion of the nasopharyngeal mucous membranes in a variety of disorders of the upper respiratory tract was included as a "combination" in McMahon's survey. We insist this is a single chemical entity product. A letter from the author says that it was included because the benzalkonium chloride has germicidal and antiseptic activity, and the phenylmercuric acetate, too, may have human activity. The point is not whether benzalkonium chloride has germicidal and antiseptic activity nor that phenylmercuric acetate has some human activity, etc, but rather what do these additives do for relief of congestion of the nasopharyngeal mucous membranes. The Food and Drug Administration as well as the AMA Drug Evaluation Book regards "Afrin" as a single chemical entity product. If one were to accept McMahon's hypothesis there would be
An Alternative Approach for Investigating the Carcinogenicity of Indoor Air Pollution: Pets as Sentinels of Environmental Cancer Risk
Authors: John A. Bukowski, Daniel Wartenberg
Journal: Environmental Health Perspectives (1997)

Traditionally, the cancer risks associated with radon,environmental tobacco smoke (ETS), and similar indoor residential exposures have been evaluated through either laboratory experiments in rodents or epidemiology studies in people. Laboratory studies have the advantage of being controlled experiments, but their utility as estimators of human risk is limited by the uncertainties of extrapolating from rodents to people and from high doses to those typically experienced in the home. These experiments also subject animals to noxious exposures, causing suffering that may be considered cruel. Traditional epidemiology studies evaluate human risk directly, at the exposure levels present in residences; however, these studies are limited by their potential for misclassification, biased recall, and uncontrolled confounding. The long time intervals involved between exposure and disease (often 30 years or more) make accurate recall particularly problematic. In this paper we discuss the limitations of these traditional approaches, especially as they relate to residential studies of radon and ETS. The problems associated with the maximum tolerated dose in rodent bioassays and exposure misclassification in traditional epidemiology are particularly examined. A third approach that supplements the traditional approaches and overcomes some of their limitations is suggested. This approach, dubbed pet epidemiology, estimates residential cancer risk by examining the exposure experience of pet dogs with naturally occurring cancers. The history of pet epidemiology is reviewed and its strengths and limitations are examined.
NCAB Opposes Travel Restrictions on NCI
Journal: JNCI Journal of the National Cancer Institute (1992)

NCAB Opposes Travel Restrictions on NCI Get access JNCI: Journal of the National Cancer Institute, Volume 84, Issue 4, 19 February 1992, Pages 227–228, https://doi.org/10.1093/jnci/84.4.227 Published: 19 February 1992